KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Research & Development (2016 - 2025)

Historic Research & Development for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $22.8 million.

  • Pacific Biosciences Of California's Research & Development fell 1046.4% to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.9 million, marking a year-over-year decrease of 3296.45%. This contributed to the annual value of $134.9 million for FY2024, which is 2791.47% down from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Research & Development of $22.8 million as of Q3 2025, which was down 1046.4% from $22.5 million recorded in Q2 2025.
  • Pacific Biosciences Of California's Research & Development's 5-year high stood at $52.9 million during Q1 2022, with a 5-year trough of $20.5 million in Q1 2021.
  • For the 5-year period, Pacific Biosciences Of California's Research & Development averaged around $37.0 million, with its median value being $42.6 million (2021).
  • Per our database at Business Quant, Pacific Biosciences Of California's Research & Development soared by 15762.6% in 2022 and then plummeted by 4629.79% in 2024.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Research & Development stood at $42.6 million in 2021, then rose by 0.11% to $42.6 million in 2022, then rose by 4.51% to $44.5 million in 2023, then crashed by 38.34% to $27.5 million in 2024, then dropped by 16.82% to $22.8 million in 2025.
  • Its last three reported values are $22.8 million in Q3 2025, $22.5 million for Q2 2025, and $29.1 million during Q1 2025.